ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2019

Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in ovarian cancer.

Jinglu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.